Arrowhead Research Corp. (ARWR)

6.55
+0.11 (+1.95%)
Exchange
NMS
Day Range
5.58 - 5.82
52 Week Range
3.07 - 9.36
Open
5.68
Avg. Vol
630,827
Market Cap
344.77M
Short ratio
15.00
PEG Ratio
-0.55
Earnings Share
-1.36
Bid
4.12
Book Value
1.23
EPS Current Year Estimate
-1.40
EPS Estimate Next Year
-1.37
Change from Year Low
2.68
Change from Year High
-3.61
Price Target 1 Year
9.69

Complete Profile

Name Arrowhead Pharmaceuticals, Inc.
Sector Healthcare
Industry Biotechnology
Address

Arrowhead Pharmaceuticals, Inc.
225 South Lake Avenue
Suite 1050
Pasadena, CA 91101
United States - Map
Phone: 626-304-3400
Fax: 626-304-3401
Website: http://www.arrowheadpharma.com

Employees 104
Executives Dr. Christopher R. Anzalone Ph.D.
Chief Exec. Officer Pres Director Chief Exec. Officer of Calando Chief Exec. Officer of Tego Chief Exec. Officer of Nantope Chief Exec. Officer of Leonardo and Chief Exec. Officer of Ablaris Therapeutics


Mr. Kenneth A. Myszkowski MBA
A 50Chief Financial Officer


Dr. Bruce D. Given M.D.
Chief Operating Officer


Dr. David L. Lewis Ph.D.
Chief Scientific Officer


Mr. Patrick O'Brien J.D.
armD 52Gen. Counsel


Holders
  • Oppenheimer Global Opportunities Fund
  • Vanguard Total Stock Market Index Fund
  • iShares Russell 2000 ETF
  • Vanguard Extended Market Index Fund
  • iShares NASDAQ Biotechnology ETF
  • JP Morgan Small Cap Growth Fund
  • Columbia Fds Var Ser Tr II-Columbia Var Port U.S. Equities F
  • JP Morgan U.S. Small Company Fund
  • iShares Russell 2000 Growth ETF
  • Vanguard Institutional Index-Inst Total Stock Market Ind